Renee Gala named next CEO of Jazz Pharmaceuticals: Gala will take over as president and CEO on August 11, 2025, following ...

TPN-101, a potent nucleoside reverse transcriptase inhibitor that specifically inhibits the LINE-1 reverse transcriptase.

Marcel Botha discusses ways the agency can ensure it gets the most accurate results possible from AI.

The new doll will include an insulin pump, a glucose monitor, and a dress featuring international symbols for diabetes ...

Varda Space Industries announced its Series C fundraiser for medicine creation in space has reached $187 million. This now ...

One of the major complaints levied against FDA by the current administration is that the approval process is too complicated, takes too long, and needs to be modernized. The new leadership pledged to ...

Life sciences marketing has long revolved around physicians. Traditionally seen as the gatekeepers of prescribing power, ...

Approval was based on results from the Phase IIIb TRAILBLAZER-ALZ 6 trial, which showed that Kisunla achieved comparable ...

ADRX-0405 is uniquely being tested during its 1a/b clinical trials. ADRX-0405 is labeled as a STEAP1 ADC (primarily ...

The full approval of Spikevax covers children aged six months through 11 years who are at increased risk for severe COVID-19, transitioning the vaccine from emergency use to full licensure.

In today’s fast-paced, innovation-fueled biopharma landscape, the traditional model of C-suite leadership is being turned on ...

One of the concerns people have when they hear FDA is using AI in the drug approval process is that many people don't have a ...